| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Talaris Therapeutics, Inc. | Chief Medical Officer | Stock Appreciation Right | 120,000 | 01 Feb 2023 | Direct | ||
| Talaris Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 120,000 | 01 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRML | Talaris Therapeutics, Inc. | 01 Feb 2023 | 2 | $0 | 4 | Chief Medical Officer | 03 Feb 2023, 15:59 |
| TRML | Talaris Therapeutics, Inc. | 10 Sep 2022 | 1 | $0 | 4 | Chief Medical Officer | 13 Sep 2022, 16:30 |
| TRML | Talaris Therapeutics, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Medical Officer | 02 Feb 2022, 17:02 |